Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
08/06/2010
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Second Quarter Financial Results
08/03/2010
Lexicon To Provide Clinical Pipeline Update And Report Second Quarter 2010 Financial Results
08/01/2010
Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs
06/21/2010
Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
06/15/2010
Lexicon to Present Clinical Data for Diabetes Drug Candidate, LX4211, at Two Major Healthcare Conferences
06/03/2010
Lexicon to Present at Two Major Healthcare Investor Conferences
05/07/2010
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 First Quarter Results
05/05/2010
Lexicon Presents Positive Outcome In IBS Patients Treated With LX1031 and Data Supporting Mechanism of Action
04/30/2010
Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2010 Financial Results
04/28/2010
Lexicon to Present at BIO International Convention
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»
Page 1 of 37
